An investigational combination of cagrilintide (an amylin analog) and semaglutide (a GLP-1 receptor agonist); it is not a single peptide or an FDA-approved combination product.
Also called: cagrilintide + semaglutide
An investigational combination of cagrilintide (an amylin analog) and semaglutide (a GLP-1 receptor agonist); it is not a single peptide or an FDA-approved combination product.
Also called: cagrilintide + semaglutide